Antihypertensive effect of Silymarin on DOCA salt induced hypertension in unilateral nephrectomized rats

Abstract

The objective of the present investigation was to evaluate the therapeutic efficacy of Silymarin in DOCA salt induced hypertension in unilateral nephrectomized rats. Unilateral nephrectomy was performed in female Wistar rats (150–200 g). A week after unilateral nephrectomy, hypertension was induced by DOCA (25 mg/kg, once a week; s.c; for 4 weeks) dispersed in cottonseed oil. The effect of Silymarin (300 mg/kg and 500 mg/kg, p. o., for 4 weeks) was evaluated in DOCA salt induced hypertensive rats. Systolic blood pressure (BP) was measured once every week during the treatment schedule. After completion of treatment schedule, heart rate, arterial blood pressure and vascular reactivity to various drugs were recorded. Rats from individual group were sacrificed, the heart was dissected out and antioxidant enzyme level SOD, CAT, GSH and TBARS were measured. Urine excretions were measured by flame photometer. Silymarin (300, 500 mg/kg/day, p.o.) significantly (p < 0.05) reduced systolic blood pressure, heart rate, basal arterial blood pressure and pressor responses to NA, Adr, PE and 5-HT in animals treated with DOCA salt as compared with DOCA-salt hypertensive rats. Silymarin significantly increased antioxidant enzyme level of SOD, CAT, GSH, urinary Na+ excretion and decreased TBARS level, urinary K+ excretion compared with DOCA hypertensive group. Silymarin exhibits significant antihypertensive activity in DOCA salt model of hypertension.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. Badyal DK, Lata H, Dadhich AP (2003) Animal model of hypertension and effect of drugs. Indian J Pharmacol 35:349–362

    CAS  Google Scholar 

  2. Balaraman R, Hingorani N, Rathod SP (1993) Studies on the antihypertensive effect of abana in rats. Indian J Pharmacol 25:209–214

    CAS  Google Scholar 

  3. Banappa SU, Basangouda MP (2009) Apocynin improves endothelial function and prevents the development of hypertension in fructose fed rat. Indian J Pharmacol 41:208–212

    Article  Google Scholar 

  4. Beers RF, Sizer IW (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 115:133–140

    Google Scholar 

  5. Bereck KH, Barron KW, Webb RL, Brody MJ (1982) Vasopressin CNS interaction in the development of DOCA hypertension. Hypertension 4:131–137

    Google Scholar 

  6. Beswick RA, Dorrance AM, Leite R, Webb RC (2001) NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38:1107–1111

    PubMed  Article  CAS  Google Scholar 

  7. Ceriello A (2008) Possible role of Oxidative stress in the pathogenesis of hypertension. Diabetes Care 31:S181–S184

    PubMed  Article  CAS  Google Scholar 

  8. Connell JM, Davies E (2005) The new biology of aldosterone. J Endocrinol 186:1–20

    PubMed  Article  CAS  Google Scholar 

  9. Dixit N, Baboota S, Kohli K, Ahmad S (2007) Silymarin: a review of Pharmacological aspects and bioavailability enhancement approaches. Indian J Pharmacol 39:172–179

    Article  CAS  Google Scholar 

  10. Edward ES, Field PF (1986) Extracellular calcium and altered vascular responsiveness in the deoxycorticosterone acetate salt-treated rat. Hypertension 6:527–532

    Google Scholar 

  11. Elio A, Soria AC, Aldo R, Eynard AB, Patricia L, Quiroga A (2007) Differential effects of quercetin and silymarin on arsenite-induced cytotoxicity in two human breast adenocarcinoma cell lines. Life Sci 81:1397–1402

    Article  Google Scholar 

  12. Ellman GL (1959) Tissue sulphydryl groups. Arch Biochem Biophysics 82:70–77

    Article  CAS  Google Scholar 

  13. Gazak R, Svobodova A, Pstova J, Sedmera P et al (2004) Oxidized derivatives of Silybin and their antiradical and antioxidant activity. Bioorgan Med Chem 12:5677–5687

    Article  CAS  Google Scholar 

  14. Han MH, Yoon WK, Hyunju Lee et al (2007) Topical application of silymarin reduces chemical-induced Irritant contact dermatitis in BALB/c mice. Inter Immunopharmacolo 7:1651–1658

    Article  CAS  Google Scholar 

  15. Katholi RE, Naftilan AJ, Oparil S (2007) Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat. Hypertension 2:266–273

    Google Scholar 

  16. Lassegue B, Griendling KK (2004) Reactive oxygen species in hypertension. Am J Hypertension 17:852–860

    Article  CAS  Google Scholar 

  17. Makino JB, Skelton MM, Zou AP, Roman RJ, Cowley AW (2002) Increased renal medullary oxidative stress produces hypertension. Hypertension 39:667–672

    PubMed  Article  CAS  Google Scholar 

  18. Misra HP, Fridovich I (1972) The generation Superoxide radical during the autooxidation of hemoglobin. J Biol Chem 247:6960–6962

    PubMed  CAS  Google Scholar 

  19. Nakagawa M, Nasjletti A (1998) Plasma rennin concentration in Deoxycorticosterone salt hypertension. Hypertension 11:411–415

    Google Scholar 

  20. Nancy L, Kanagur R, Webb C (1996) Increased responsiveness and decreased express of G. proteins in DOCA hypertension. Hypertension 27:740–745

    Google Scholar 

  21. Niehaus WG, Samuelsson B (1968) Formation of malondialdehyde from phospholipids arachidonate during microsomal lipid peroxidation. Eur J Biochem 6:126–130

    PubMed  Article  CAS  Google Scholar 

  22. Pradhan SC, Girish C (2006) Hepatoprotective herbal drug, Silymarin from experimental pharmacology to clinical medicine. Indian J Med Res 491504

  23. Saggu H, Cooksey J, Dexter D (1989) A selective increase in particulate Superoxide dismutase activity in Parkinsonin subtansia nigra. J Neurochem 53:692–697

    PubMed  Article  CAS  Google Scholar 

  24. Seyle H, Bois P (1957) The hormonal production of nephrosclerosis and periarteritis nodosa in the primate. Br Med J 1:183–186

    Article  Google Scholar 

  25. Stephen M, Sagar B et al (2007) Future directions for research on Silybum marianum for cancer patients. Integr Cancer Therap 6:166–173

    Article  Google Scholar 

  26. Toklu HZ, Tuba TA, Erkanli G, Yuksel M (2007) Silymarin, the antioxidant compound of Silybum marianum, protects against burn induced oxidative skin injury. Burns 33:908–916

    PubMed  Article  Google Scholar 

  27. Trease EG, Evans WC (1983) Textbook of pharmacognosy, 12th edn. Alden Press, Singapore

    Google Scholar 

  28. Vaziri ND, Rodriguez-Lturbe B (2006) Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Cli Pract Nephrol 2:582–593

    Article  CAS  Google Scholar 

  29. Vogel HG, Wolfgand WH (eds) (1997) Drug discovery and evaluation-pharmacological assays, 2nd edn. Springer publication, Germany, pp 122–124

    Google Scholar 

  30. Weiss R, Fintelmann V (2000) Herbal medicine, 2nd edn. Thieme, Stuttgart, pp 109–111

    Google Scholar 

Download references

Acknowledgement

Authors are thankful to Management and Principal for providing all facilities for the research work. Authors are also thankful to University of Pune for funding research work and Manager of MICRO Lab PVt. LTd. GOA for providing gift sample of Silymarin.

Author information

Affiliations

Authors

Corresponding author

Correspondence to G. B. Jadhav.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jadhav, G.B., Upasani, C.D. Antihypertensive effect of Silymarin on DOCA salt induced hypertension in unilateral nephrectomized rats. Orient Pharm Exp Med 11, 101–106 (2011). https://doi.org/10.1007/s13596-011-0018-2

Download citation

Keywords

  • Hypertension
  • Silymarin
  • Deoxycorticosterone acetate
  • Antioxidant